Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting <scp>PAR1</scp>-Reference-Cited by-同舟云学术

Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1

Published:2022-02-28 Issue:4 Volume:36 Page:1807-1821
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Wang Ming¹,Ren Shanfa¹²,Bi Zhun¹,Zhang Liang³,Cui Mengqi¹²,Sun Ronghao¹,Bao Jiali¹²,Gao Dandi¹²,Yang Bo³,Li Xiaoping³,Li Mingjiang³,Xiao Ting¹²,Zhou Hong‐gang¹²^ORCID,Yang Cheng¹²

Affiliation:

1. State Key Laboratory of Medicinal Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research Nankai University Tianjin People's Republic of China

2. Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine Tianjin People's Republic of China

3. Department of Thoracic Surgery Tianjin First Central Hospital, Nankai University Tianjin People's Republic of China

Funder

National Natural Science Foundation of China

Tianjin Science and Technology Committee

Nankai University

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7427

Reference41 articles.

1. Featured Article: Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells

2. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

3. PAR1 plays a role in epithelial malignancies: Transcriptional regulation and novel signaling pathway

4. Myricetin Induces Protective Autophagy by Inhibiting the Phosphorylation of mTOR in HepG2 Cells

5. Melittin inhibits hypoxia‐induced vasculogenic mimicry formation and epithelial‐mesenchymal transition through suppression of HIF‐1alpha/Akt pathway in liver cancer;Chen Q.;Evidence‐Based Complementary and Alternative Medicine,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention;Cancer Prevention Research;2024-05-07

2. Novel insight into the therapeutical potential of flavonoids from traditional Chinese medicine against cerebral ischemia/reperfusion injury;Frontiers in Pharmacology;2024-02-29

3. Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula;Journal of Visualized Experiments;2024-01-26

4. Research progress on natural products against hepatocellular carcinoma;BIOCELL;2024

5. Myricetin: a potential plant-derived anticancer bioactive compound—an updated overview;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-04-21